Search

Your search keyword '"Rhino-orbital-cerebral mucormycosis"' showing total 189 results

Search Constraints

Start Over You searched for: Descriptor "Rhino-orbital-cerebral mucormycosis" Remove constraint Descriptor: "Rhino-orbital-cerebral mucormycosis"
189 results on '"Rhino-orbital-cerebral mucormycosis"'

Search Results

1. COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients.

2. Rhino-orbital-cerebral mucormycosis in acute myeloid leukemia patients: a case series from Sri Lanka.

Catalog

Books, media, physical & digital resources

3. Rapidly Developing and Elusive Rhino-Orbital-Cerebral Mucormycosis.

4. A clinical study of rhino-orbital-cerebral mucormycosis during the COVID-19 pandemic in western Maharashtra

5. Angioinvasive Rhino-Orbital-Cerebral Mucormycosis in a Patient with Type 2 Diabetes Mellitus: A Complex and Lethal Cause of Stroke.

6. An insight into the pathophysiology of mucormycosis: Lesson learnt during COVID pandemic.

7. A clinical study of rhino-orbital-cerebral mucormycosis during the COVID-19 pandemic in western Maharashtra.

8. Rhino-orbital-cerebral mucormycosis caused by Rhizopus arrhizus diagnosis via metagenomics next-generation sequencing: a case report.

9. To determine the role of transcutaneous retrobulbar amphotericin B in COVID-19-related rhino-orbital-cerebral mucormycosis.

10. Rare case of a chronic rhinocerebral mucormycosis

11. Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report

12. Rhino orbital cerebral mucormycosis: A life-threatening complication of coronavirus diseases 2019 in an uncontrolled diabetic patient

13. Survival from Rhino-Orbital-Cerebral Mucormycosis in SARS-CoV-2-Positive Diabetic Patients: Two Case Reports.

14. Rhino orbital cerebral mucormycosis: A life-threatening complication of coronavirus diseases 2019 in an uncontrolled diabetic patient.

15. Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report.

16. Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India.

17. Lack of surgical resection is associated with increased early mortality in hematological patients complicated with rhino-orbital-cerebral mucormycosis.

18. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.

19. Imaging Spectrum of Coronavirus Disease- 2019 Associated Rhino-Orbital-Cerebral Mucormycosis; From Sinonasal Inflammation to Intracranial Involvement.

20. Clinical profile of COVID-19-associated mucormycosis patients and the clinical suspects: a descriptive audit

21. Mucormycosis: A 14-Year Retrospective Study from a Tertiary Care Center in Lebanon.

22. An Unusual Presentation of Rhino-Orbital Mucormycosis with MDR-TB: an Unforeseen Challenge for Treatment Post COVID-19.

23. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review

24. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital–cerebral mucormycosis: preserving the salvageable.

25. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.

26. Alternating pattern of rhino-orbital–cerebral mucormycosis with COVID-19 in diabetic patients.

27. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.

28. Clinical study of rhino-orbital-cerebral mucormycosis in COVID-19 patients in a regional institute in South India.

29. COVID-19-related Rhino-orbital-cerebral Mucormycosis.

31. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India

32. Mucormycosis in post-covid patients: An epidemic in pandemic

33. Coronavirus disease 2019-associated mucormycosis of the head-and-neck area: A new rise of dreaded black fungus in the current pandemic

34. Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series.

35. Mysterious alarming mucormycosis: Anesthetic challenges in a series of four cases.

36. Coronavirus disease 2019-associated mucormycosis of the head-and-neck area: A new rise of dreaded black fungus in the current pandemic.

37. COVID-19 associated mucormycosis: Staging and management recommendations (Report of a multi-disciplinary expert committee)

38. Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement

39. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report

40. Central retinal vein occlusion as primary ocular manifestation of rhino-orbital-cerebral mucormycosis: A case report

41. Mucormycosis in post-covid patients: An epidemic in pandemic.

42. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1

43. Expert opinion – Rhino-orbital-cerebral mucormycosis

44. COVID-19–associated central nervous system mucormycosis

45. Mucormycosis in COVID-19 patients

46. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.

47. Post-COVID-19 Related Rhinocerebral Mucormycosis in Bulgaria: A Report of Three Cases.

48. Central retinal vein occlusion as primary ocular manifestation of rhino-orbital-cerebral mucormycosis: A case report.

49. Mucormycosis in COVID-19 patients.

50. Correlation of the severity of mucormycosis with levels of inflammatory markers in COVID-19 patients